BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 29800576)

  • 1. Evaluating dendritic cells as an in vitro screening tool for immunotherapeutic formulations.
    El-Murr T; Patel A; Sedlak C; D'Souza-Lobo B
    J Immunol Methods; 2018 Aug; 459():55-62. PubMed ID: 29800576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The TLR-7 agonist, imiquimod, enhances dendritic cell survival and promotes tumor antigen-specific T cell priming: relation to central nervous system antitumor immunity.
    Prins RM; Craft N; Bruhn KW; Khan-Farooqi H; Koya RC; Stripecke R; Miller JF; Liau LM
    J Immunol; 2006 Jan; 176(1):157-64. PubMed ID: 16365406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of human monocyte-derived dendritic cells in vitro by the biological response modifier arabinoxylan rice bran (MGN-3/Biobran).
    Ghoneum M; Agrawal S
    Int J Immunopathol Pharmacol; 2011; 24(4):941-8. PubMed ID: 22230400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imiquimod enhances the potency of an exogenous BM-DC based vaccine against mouse melanoma.
    Ren S; Wang Q; Zhang Y; Song Y; Dong X; Zhang W; Qin X; Liu M; Yu T
    Int Immunopharmacol; 2018 Nov; 64():69-77. PubMed ID: 30149266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms by Which Dendritic Cells Present Tumor Microparticle Antigens to CD8
    Ma J; Wei K; Zhang H; Tang K; Li F; Zhang T; Liu J; Xu P; Yu Y; Sun W; Zhu L; Chen J; Zhou L; Liang X; Lv J; Fiskesund R; Liu Y; Huang B
    Cancer Immunol Res; 2018 Sep; 6(9):1057-1068. PubMed ID: 30018046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A high-throughput microparticle microarray platform for dendritic cell-targeting vaccines.
    Acharya AP; Clare-Salzler MJ; Keselowsky BG
    Biomaterials; 2009 Sep; 30(25):4168-77. PubMed ID: 19477505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eliciting cytotoxic T lymphocytes against human laryngeal cancer-derived antigens: evaluation of dendritic cells pulsed with a heat-treated tumor lysate and other antigen-loading strategies for dendritic-cell-based vaccination.
    Wei FQ; Sun W; Wong TS; Gao W; Wen YH; Wei JW; Wei Y; Wen WP
    J Exp Clin Cancer Res; 2016 Jan; 35():18. PubMed ID: 26795730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast carcinoma cell lysate-pulsed dendritic cells cross-prime MUC1-specific CD8+ T cells identified by peptide-MHC-class-I tetramers.
    Bohnenkamp HR; Coleman J; Burchell JM; Taylor-Papadimitriou J; Noll T
    Cell Immunol; 2004; 231(1-2):112-25. PubMed ID: 15919376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulatory properties of bacteriophage derived dsRNA of different size and their use as anticancer vaccine adjuvants.
    Dobrovolskienė N; Balevičius R; Mlynska A; Žilionytė K; Aleksander Krasko J; Strioga M; Lieknina I; Pjanova D; Pašukonienė V
    Vaccine; 2024 Jan; 42(3):512-521. PubMed ID: 38184395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting CD4(+) T-helper cells improves the induction of antitumor responses in dendritic cell-based vaccination.
    Aarntzen EH; De Vries IJ; Lesterhuis WJ; Schuurhuis D; Jacobs JF; Bol K; Schreibelt G; Mus R; De Wilt JH; Haanen JB; Schadendorf D; Croockewit A; Blokx WA; Van Rossum MM; Kwok WW; Adema GJ; Punt CJ; Figdor CG
    Cancer Res; 2013 Jan; 73(1):19-29. PubMed ID: 23087058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinically feasible approaches to potentiating cancer cell-based immunotherapies.
    Seledtsov VI; Goncharov AG; Seledtsova GV
    Hum Vaccin Immunother; 2015; 11(4):851-69. PubMed ID: 25933181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery of TLR7 agonist to monocytes and dendritic cells by DCIR targeted liposomes induces robust production of anti-cancer cytokines.
    Klauber TCB; Laursen JM; Zucker D; Brix S; Jensen SS; Andresen TL
    Acta Biomater; 2017 Apr; 53():367-377. PubMed ID: 28153581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced stimulation of anti-breast cancer T cells responses by dendritic cells loaded with poly lactic-co-glycolic acid (PLGA) nanoparticle encapsulated tumor antigens.
    Iranpour S; Nejati V; Delirezh N; Biparva P; Shirian S
    J Exp Clin Cancer Res; 2016 Oct; 35(1):168. PubMed ID: 27782834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo evaluations of human papillomavirus type 16 (HPV16)-derived peptide-loaded dendritic cells (DCs) with a CpG oligodeoxynucleotide (CpG-ODN) adjuvant as tumor vaccines for immunotherapy of cervical cancer.
    Wang HL; Xu H; Lu WH; Zhu L; Yu YH; Hong FZ
    Arch Gynecol Obstet; 2014 Jan; 289(1):155-62. PubMed ID: 23912529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marina crystal minerals (MCM) activate human dendritic cells to induce CD4+ and CD8+ T cell responses in vitro.
    Ghoneum MH; Ogura T; Gimzewski JK; Ghoneum AD; Henary MC; Agrawal S
    Int J Immunopathol Pharmacol; 2018; 32():2058738418797768. PubMed ID: 30270704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The adjuvants aluminum hydroxide and MF59 induce monocyte and granulocyte chemoattractants and enhance monocyte differentiation toward dendritic cells.
    Seubert A; Monaci E; Pizza M; O'Hagan DT; Wack A
    J Immunol; 2008 Apr; 180(8):5402-12. PubMed ID: 18390722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and immunological evaluation of anti-CD205-tailored PLGA-based nanoparticulate cancer vaccine.
    Jahan ST; Sadat SM; Haddadi A
    Int J Nanomedicine; 2018; 13():367-386. PubMed ID: 29391795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lead effects on development and function of bone marrow-derived dendritic cells promote Th2 immune responses.
    Gao D; Mondal TK; Lawrence DA
    Toxicol Appl Pharmacol; 2007 Jul; 222(1):69-79. PubMed ID: 17512567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Part I: targeted particles for cancer immunotherapy.
    Hamdy S; Haddadi A; Ghotbi Z; Hung RW; Lavasanifar A
    Curr Drug Deliv; 2011 May; 8(3):261-73. PubMed ID: 21453265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of toll-like receptor 4 on dendritic cells is significant for anticancer effect of dendritic cell-based immunotherapy in combination with an active component of OK-432, a streptococcal preparation.
    Okamoto M; Furuichi S; Nishioka Y; Oshikawa T; Tano T; Ahmed SU; Takeda K; Akira S; Ryoma Y; Moriya Y; Saito M; Sone S; Sato M
    Cancer Res; 2004 Aug; 64(15):5461-70. PubMed ID: 15289356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.